Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

Impact of histological components on selecting limited lymphadenectomy for lung adenocarcinoma ≤ 2 cm

Lung Cancer | Oct 02, 2020 Lung/Thoracic Oncology

Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib

Lung Cancer | Oct 02, 2020 Lung/Thoracic Oncology

Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events?: Results from a retrospective cohort study

BMJ Open | Oct 01, 2020 Lung/Thoracic Oncology

The relation between distant metastasis and genetic change type in stage IV lung adenocarcinoma patients at diagnosis

The Clinical Respiratory Journal | Oct 01, 2020 Lung/Thoracic Oncology

Radioactive seeds insertion with chemotherapy for advanced non‐small‐cell lung cancer: A meta‐analysis

The Clinical Respiratory Journal | Oct 01, 2020 Lung/Thoracic Oncology

KRAS^G12C inhibition with sotorasib in advanced solid tumors

New England Journal of Medicine | Sep 28, 2020 Lung/Thoracic Oncology

Plinabulin vs pegfilgrastim for prevention of chemotherapy-induced neutropenia in adults with NSCLC

JAMA | Sep 28, 2020 Lung/Thoracic Oncology

Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer

Lung Cancer | Sep 28, 2020 Lung/Thoracic Oncology

Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: A cost-effectiveness analysis

BMJ Open | Sep 28, 2020 Lung/Thoracic Oncology

Switch maintenance chemotherapy vs observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non–small cell lung cancer: IFCT-1201 MODEL trial

European Journal of Cancer | Sep 27, 2020 Lung/Thoracic Oncology

« Prev 1 … 38 39 40 41 42 … 149 Next »

Impact of histological components on selecting limited lymphadenectomy for lung adenocarcinoma ≤ 2 cm

Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib

Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events?: Results from a retrospective cohort study

The relation between distant metastasis and genetic change type in stage IV lung adenocarcinoma patients at diagnosis

Radioactive seeds insertion with chemotherapy for advanced non‐small‐cell lung cancer: A meta‐analysis

KRAS^G12C inhibition with sotorasib in advanced solid tumors

Plinabulin vs pegfilgrastim for prevention of chemotherapy-induced neutropenia in adults with NSCLC

Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer

Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: A cost-effectiveness analysis

Switch maintenance chemotherapy vs observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non–small cell lung cancer: IFCT-1201 MODEL trial

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Impact of histological components on selecting limited lymphadenectomy for lung adenocarcinoma ≤ 2 cm

Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib

Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events?: Results from a retrospective cohort study

The relation between distant metastasis and genetic change type in stage IV lung adenocarcinoma patients at diagnosis

Radioactive seeds insertion with chemotherapy for advanced non‐small‐cell lung cancer: A meta‐analysis

KRASG12C inhibition with sotorasib in advanced solid tumors

Plinabulin vs pegfilgrastim for prevention of chemotherapy-induced neutropenia in adults with NSCLC

Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer

Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: A cost-effectiveness analysis

Switch maintenance chemotherapy vs observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non–small cell lung cancer: IFCT-1201 MODEL trial

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic

KRAS^G12C inhibition with sotorasib in advanced solid tumors